April 22, 2012

A lot has happened across GlaxoSmithKline’s consumer division in the past year. Drug Store News spoke with GSK Consumer chief marketing officer John Graham and chief customer officer Keith Loranger about the next move to be made out of the consumer division’s new playbook.

June 23, 2015

The Food and Drug Administration is concerned that too great a deviance from a reference drug appearance could affect compliance. 

June 15, 2015

DSN examines chain pharmacy, including in-depth coverage of technology, automation and generics, in this multi-page report.

June 15, 2015

 "As it stands now, TPP will make it harder for the U.S. generic industry to sell its products overseas," GPhA's Ralp Neas reported. 

June 11, 2015

According to a new report from national trade organization AHAA: the Voice of Hispanic Marketing, pharmaceutical marketers have room for improvement when it comes to Hispanic advertising.

June 5, 2015

Cardinal Health's acquisition of The Harvard Drug Group "further utilizes Red Oak, our joint venture with CVS Health to source generics," CEO says. 

June 4, 2015

The Federal Trade Commission plans to examine the advertising practices of the homeopathy industry. 

June 3, 2015

Pet medications will realize a CAGR of 5% through 2018, Packaged Facts projected.

June 2, 2015

Actavis and Perrigo's application for a generic guaifenesin/PSE product approved by FDA. 

June 2, 2015

Perrigo's new OTC product portfolio acquired out of the GSK/Novartis joint venture are sold primarily throughout Europe and Brazil. 

May 29, 2015

The Food and Drug Administration Friday announced that it had approved Rapamune (sirolimus), distributed by Pfizer’s Wyeth Pharmaceuticals, as a treatment for the rare lung disease lymphangioleiomyomatosis (LAM). 

May 28, 2015

The AARP Public Policy Institute’s latest Rx Price Watch Report shows that, despite an overall 4% decrease in price in 2013, the prices of generic drugs seem to be dropping at the slowest rate since 2006. 

May 20, 2015

Mergers and acquisitions among pharmaceutical companies has kicked into high gear this year, mirroring the larger trend sweeping across the entire spectrum of the health care industry since the implementation of the Affordable Care Act two years ago.

May 19, 2015

DSN examines chain pharmacy — including in-depth coverage of retail clinics, generics, consolidations, kiosks and more — in this multi-page report.

May 18, 2015

Endo buys Par in a $8 billion deal. 

May 13, 2015

The FDA will review GDUFA in June. 

May 13, 2015

HDMA is teaming with GIRP (the European Association of Pharmaceutical Full-line Wholesalers) and IFPW on the second annual International Pharmaceutical Distribution Conference in Brussels, Belgium. 

May 7, 2015

Kline reports OTC growth of 1.4% to more than $24 billion. 

April 22, 2015

The dramatic increase in the price of generic drugs last year is expected to continue for the rest of 2015 and even into next year, according to those who closely monitor the market.

April 22, 2015

Following Perrigo's rejection of a Mylan offer, Teva moves forward with its proposed acquistion of Mylan. 

April 21, 2015

A new PhRMA report released Monday found that branded manufacturers invested $51.2 billion last year in R&D. 

April 21, 2015

The National Minority Quality Forum on Tuesday honored PhRMA's John Castellani, for helping to increase diversity in clinical trials. 

April 21, 2015

Teva Pharmaceutical on Tuesday made a move for Mylan in a $40 billion deal barring Mylan's proposed acquisition of Perrigo. 

April 20, 2015

DSN examines chain pharmacy — including in-depth coverage of provider status, generics, pharmacy deserts, point-of-care testing and more — in this multi-page report.